Intermittent oral administration of iron oxide nanoparticles modulates iron homeostasis, hematological, inflammatory, and organ-specific responses in iron-deficient rats
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-06 · 399 (9) · 13417-13435
DOI: 10.1007/s00210-026-05211-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 26.03.2026. Verfasst von Yousif Taha Hussein und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biology Department, College of Science, University of Sulaimani, Sulaymaniyah, 46001, Kurdistan Region, Iraq. Yousif.hussein@spu.edu.iq. Hauptthemen laut MEDLINE: Iron, Anemia, Iron-Deficiency, Magnetic Iron Oxide Nanoparticles. Die Arbeit nennt 89 Literaturangaben.
Abstract (Originalsprache)
Iron oxide nanoparticles (Fe₃O₄ NPs) are increasingly incorporated into biomedical and pharmaceutical applications and as alternative iron sources for treating anemia; however, their systemic effects under nonconventional dosing regimens remain incompletely understood. Therefore, this study aimed to conduct a comprehensive dose-response assessment of intermittent oral Fe₃O₄ nanoparticle dosing in iron-deficient rats. Iron deficiency anemia (IDA) was induced in male Wistar rats via an iron-deficient diet. The anemic rats received oral Fe₃O₄ nanoparticles (25-200 mg/kg) or ferrous sulfate (FS, 45 mg/kg) three times weekly for four weeks. Hematological recovery, iron status, IL-6 and hepcidin levels, organ function biomarkers, and histomorphometric parameters were assessed. IONPs restored iron homeostasis in a dose-dependent manner. Doses of 100 and 200 mg/kg normalized hemoglobin, hematocrit, and RBC counts to levels comparable to FS and the healthy controls, alongside significant improvements in serum iron, transferrin saturation, and ferritin. Although IONPs triggered a dose-dependent increase in IL-6 and hepcidin, the hepcidin response remained significantly lower than in the FS group. Histopathological analysis revealed a dose-dependent, hepatorenal toxicity profile. In conclusion, intermittent oral Fe₃O₄ NPs effectively correct anemia and restore iron parameters. However, these beneficial effects are counterbalanced by hepatorenal toxicity, suggesting the critical need for precise dose optimization in translational studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biology Department, College of Science, University of Sulaimani, Sulaymaniyah, 46001, Kurdistan Region, Iraq. Yousif.hussein@spu.edu.iq.
- Department of Medical Laboratory Techniques, Halabja Technical Institute, Sulaimani Polytechnic University, Halabja, Iraq. Yousif.hussein@spu.edu.iq.
- Biology Department, College of Science, University of Sulaimani, Sulaymaniyah, 46001, Kurdistan Region, Iraq.
Zitieren
APA
Hussein, Y. T., Mohammed, S. M., & Rahman, F. (2026). Intermittent oral administration of iron oxide nanoparticles modulates iron homeostasis, hematological, inflammatory, and organ-specific responses in iron-deficient rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(9), 13417-13435. https://doi.org/10.1007/s00210-026-05211-1
Vancouver
Hussein YT, Mohammed SM, Rahman F. Intermittent oral administration of iron oxide nanoparticles modulates iron homeostasis, hematological, inflammatory, and organ-specific responses in iron-deficient rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(9):13417-13435. doi:10.1007/s00210-026-05211-1
BibTeX
@article{Hussein2026,
author = {Hussein, Yousif Taha and Mohammed, Sulaf Mustafa and Rahman, Fryad},
title = {Intermittent oral administration of iron oxide nanoparticles modulates iron homeostasis, hematological, inflammatory, and organ-specific responses in iron-deficient rats},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {9},
pages = {13417--13435},
doi = {10.1007/s00210-026-05211-1}
}
EUVIMED